Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.50    -0.10 (-3.85%)
Bid:
2.50
Ask:
2.60
Spread: 0.10 (4.00%)
Market Cap: £2.58m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Board Updates

2 Jul 2020 10:42

RNS Number : 8591R
Litigation Capital Management Ltd
02 July 2020
 

2 July 2020

 

Litigation Capital Management Limited

(LCM or the Company)

 

Board Updates

 

Litigation Capital Management Limited (AIM:LIT), specialist alternate asset manager and a leading international provider of disputes financing solutions, provides the following update:

 

· LCM currently looking to expand the geographic market reach of its Non-Executive Directors in line with LCM's business plan

· Steve McLean steps down as non-executive director as part of this upcoming Board realignment

· Minor delays in the CEO relocating to London due to COVID-19

 

LCM is at an advanced stage in the search to add additional Non-Executive Directors (NED) to the Board. As the Company strengthens its market positioning in the Northern Hemisphere, including the UK and Europe, as well as transitioning its management to the London office, it looks to new NED appointments to bring significant experience in these markets. As part of this upcoming restructuring, Steve McLean has kindly agreed to resign his position on the board effective as at 30 June 2020.

 

Steve was appointed to LCM's board as a NED prior to the Company's IPO on the Australian Securities Exchange. Steve brought with him significant in-region equity capital markets experience and has been a very valuable member of LCM's board during the building of its business, particularly in the APAC region.

 

LCM expects to be in a position to make an announcement as to a new Non-Executive board member in the near future.

 

Jonathan Moulds, Chairman of LCM, commented: "Steve has been a strong supporter of LCM through two IPOs, one on the Australian Securities Exchange and then on the London Stock Exchange:AIM as a Non-Executive board member. As LCM's business expands into new global markets, it will benefit from board experience in those large economies. We will continue to have access to Steve and his experience was a long-term supporter of the business. I thank him for his significant contribution to the growth of LCM over a number of years"

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

 

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

 

 

 

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

 

 

Alma PR

Tel: 020 3405 0205

Rebecca Sanders-Hewett

LCM@almapr.co.uk

Justine James

 

David Ison

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a global provider of disputes finance which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is fund and/or asset management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Corporate portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

 

Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOASSUSUEESSEDW
Date   Source Headline
22nd Sep 20207:00 amRNSFinal Results
10th Sep 20202:57 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSNotice of Results
24th Aug 20207:00 amRNSFunding of Corporate Portfolio Transaction
18th Aug 20207:00 amRNSAppointment of Non-Executive Director
13th Aug 20207:16 amRNSDisputes Finance Facility with Global Law Firm
10th Jul 20207:04 amRNSMarket Update
6th Jul 20204:40 pmRNSSecond Price Monitoring Extn
6th Jul 20204:35 pmRNSPrice Monitoring Extension
2nd Jul 202010:42 amRNSBoard Updates
26th May 20207:00 amRNSAustralian Regulation of Litigation Funders
22nd May 20204:41 pmRNSSecond Price Monitoring Extn
22nd May 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSConclusion of Joint Venture Arrangement
3rd Apr 20207:08 amRNSManagement Update and Corporate Reorganisation
24th Mar 20207:00 amRNSFinal closure of US$150 million fund
23rd Mar 20207:41 amRNSDirector/PDMR Shareholding
17th Mar 20207:00 amRNSHalf-year Report
10th Mar 20207:00 amRNSFirst close of a new US$150 million fund
13th Feb 20207:00 amRNSNotice of Results
6th Feb 202012:07 pmRNSSecond Price Monitoring Extn
6th Feb 202012:02 pmRNSPrice Monitoring Extension
20th Dec 20198:04 amRNSCase Investment Settlement Update
16th Dec 20194:41 pmRNSSecond Price Monitoring Extn
16th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 201912:07 pmRNSSecond Price Monitoring Extn
11th Dec 201912:02 pmRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSCapital Markets Event and Third-Party Fund Update
2nd Dec 20197:00 amRNSNotice of Dividend Currency Exchange Rate
21st Nov 20199:30 amRNSHolding(s) in Company
21st Nov 20198:25 amRNSResult of AGM
18th Nov 201912:23 pmRNS2019 Annual Report & Accounts
12th Nov 201912:07 pmRNSSecond Price Monitoring Extn
12th Nov 201912:02 pmRNSPrice Monitoring Extension
6th Nov 20197:00 amRNSAppointment of Joint Broker
1st Nov 201911:23 amRNSIncentive Awards
16th Oct 20198:00 amRNSNotice of Annual General Meeting
30th Sep 201912:00 pmRNSHolding(s) in Company
30th Sep 201912:00 pmRNSHolding(s) in Company
13th Sep 20193:01 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSFinal Results
2nd Sep 20197:30 amRNSNotice of Results
17th Jul 201910:42 amRNSHolding(s) in Company
28th Jun 201911:44 amRNSConditional Settlement of Litigation Project
13th Jun 20197:00 amRNSFunding of Corporate Portfolio Transaction
3rd Jun 20198:59 amRNSNotice of Dividend Currency Exchange Rate
28th May 20197:42 amRNSCourt Approval Settlement and Pipeline Update
8th Apr 201910:14 amRNSHolding(s) in Company
5th Apr 201912:18 pmRNSHolding(s) in Company
1st Apr 20199:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.